Roivant Sciences Ltd.
USD28.25
-0.84 (-2.89%)
CEO
Matthew Gline
IPO Date
2020-12-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
GB
Open
$28.71
Prev. Close
$29.09
Day Low
$27.93
Day High
$28.87
52W Low
$10.71
52W High
$32.79
Market Cap
$20.32B
Volume
5.07M
| 200,000 |
| $3.85 |
| 22 May 2026 | Venker Eric | President & Immunovant CEO | S-Sale | Disposed | 200,000 | $30.27 |
| 22 May 2026 | Venker Eric | President & Immunovant CEO | M-Exempt | Disposed | 200,000 | $3.85 |
| 22 May 2026 | Pulik Richard | CFO | F-InKind | Disposed | 18,962 | $32.41 |
| 22 Apr 2026 | Venker Eric | President & Immunovant CEO | M-Exempt | Acquired | 200,000 | $3.85 |
| 22 Apr 2026 | Venker Eric | President & Immunovant CEO | S-Sale | Disposed | 200,000 | $29.59 |
| 22 Apr 2026 | Venker Eric | President & Immunovant CEO | M-Exempt | Disposed | 200,000 | $3.85 |
| 22 Apr 2026 | Pulik Richard | CFO | A-Award | Acquired | 60,644 | $0.00 |
| 22 Apr 2026 | Pulik Richard | CFO | A-Award | Acquired | 84,026 | $29.08 |